Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NASDAQ:TXMD)

6.17
Delayed Data
As of 4:00pm ET
 -0.02 / -0.32%
Today’s Change
3.50
Today|||52-Week Range
8.30
+2.15%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close6.19
Today’s open6.15
Day’s range6.10 - 6.21
Volume1,135,049
Average volume (3 months)3,061,518
Market cap$1.3B
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book9.55

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...+0.51+2.95%
ESPREsperion Therapeutic...-0.88-1.16%
BHVNBiohaven Pharmaceuti...+2.04+7.58%
FWPForward Pharma A/S+0.01+0.23%
Data as of 4:02pm ET, 01/18/2018

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts